FDA’s Pazdur Blames Trial Design Errors For Some PD-1/L1 Failures, Foreshadows Potential Agency Leniency

 
• By Sarah Karlin-Smith
  
Richard Pazdur
Rick Pazdur And Other Oncology Center of Excellence Leaders Weighed In On Checkpoint Inhibitors
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D